← All stocks

TREACE MEDICAL CONCEPTS, INC.

TMCI Net buying
CIK 0001630627 #3615 in the set updated 17 Sep 2026
Bought (1 mo)
$246.65K
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$246.65K
+$246.65K against sales at will

By person

13 insiders · 3 transactions
42.5×

John T. Treace holds 42.5 times base salary in stock. $32.13M of shares against $755.35K in salary for 2025.

Salary from the company's own proxy. The shares are what John T. Treace last reported holding, valued at $4.34, the price Common Stock was last bought or sold at on the open market here, on 24 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Treace John T.
Chief Executive Officer
$246.65K (3)
+$246.65K
7,404,383
11.39%
$32.13M
+14.0%
MOTT RICHARD W
Director
1,096,861
1.69%
$4.76M
+2.2%
Hair Mark
Chief Financial Officer
914,900
1.41%
$3.97M
+149.3%
Elder Scot Michael
Chief Legl & Comp Off, CorpSec
778,683
1.20%
$3.38M
+227.3%
Scanlan Sean F.
Chief Innovation Officer
679,863
1.05%
$2.95M
+237.9%
Guglielmino Gaetano
Chief Commercial Officer
490,901
0.7548%
$2.13M
Berutti Aaron
SVP, Sales
205,092
0.3154%
$889.94K
+44.1%
BAKEWELL JOHN K
Director
204,056
0.3138%
$885.44K
+35.9%
Jain Deepti
Director
100,243
0.1541%
$434.97K
+116.4%
Kiernan Jane E
Director
93,949
0.1445%
$407.66K
+134.7%
Hanna Betsy
Director
75,243
0.1157%
$326.49K
+252.8%
Berry Lance A
Director
74,593
0.1147%
$323.67K
+260.8%
HAMILTON LAWRENCE W
Director
74,056
0.1139%
$321.34K
+267.7%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 26 Apr 2021